All team members
Dr Eva Ehlich
Partner
German Patent Attorney
European Patent Attorney
Chemist
Eva represents European, US and Japanese companies in the chemical, biochemical and pharmaceutical sectors whom she advises and assists in prosecuting, defending, enforcing and challenging IP rights in Germany, Europe and worldwide. Along with preparing freedom-to-operate and validity analyses she has experience in patent litigation and strategic patent filing, especially in the area of drug delivery, pharmaceutics and medical uses (small molecules and biologics) as well as in coordinating international patent portfolios and freedom-to-operate strategies. Eva has received numerous recognitions for her professional activities as a patent attorney.
"Eva Ehlich is another wise choice for international briefs – her focus is on advising innovative US and Japanese pharmaceutical companies on filing strategies and worldwide portfolio management."
– IAM Patent 1000, 2020
"Eva Ehlich stands out due to the rare ability, to combine thoroughness and pragmatism. She delivers excellent results."
– Legal 500 EMEA, 2020
"The small molecule and biologics know-how of chemist Eva Ehlich is highly prized by pharmaceutical companies across Europe, the United States and Japan."
– IAM Patent 1000, 2021
"Eva Ehlich: Excellent knowledge of the industry; years of experience; excellent strategic thinking; holistic approach."
– Legal 500 DE, 2022
„valuable input regarding FTOs, prosecution and oppositions” (client)
– JUVE Patent, 2021
“An extremely safe pair of hands for complex IP issues and top-level portfolio strategy in the pharmaceutical and biotechnology space, Eva Ehlich is commercially and culturally astute and easily grapples with the complexities and politics of larger international projects.”
– IAM 300, 2022
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity opinions
- Opposition and nullity proceedings
- Patent litigation
- Recommended in Legal 500 Deutschland 2017, 2018, 2019, 2020, 2021, 2022, 2023
- Listed in IAM Strategy 300 Global Leaders 2022, 2023
- "Highly recommended attorney" in JUVE Patent Rankings Germany 2021, 2022
- Ranked as "Excellent" in the Leaders League Rankings Germany 2022 in the categorie Patent Prosecution
- Featured among Managing IP’s Top 250 Women in IP 2022
- Recommended by IAM Strategy 300 as the World's leading IP Strategist, 2021, 2022
- Recommended in IAM Patent 1000 “World’s Leading Patent Professionals” 2020, 2021, 2022
- Recommended in MIP IP Stars 2017, 2018, 2019, 2020, 2021, 2022
- "Frequently recommended lawyer" in the JUVE Handbook of Commercial Law Firms 2017/ 2018, 2017/2018, 2018/2019, 2019/2020, 2020/2021, 2021/2022
- Recommended in Handelsblatt | Best Lawyers "Germany's Best Lawyers" 2019, 2020, 2021, 2022
- Recommended in Legal 500 EMEA 2019, 2020, 2021, 2022
- Interview IAM Strategy 300 Global Leaders, 2023
- JUVE Handbook 2021/2022: Co-publishing article on the topic of „Chancen und Stolpersteine bei Videoverhandlungen am EPA“
- What is Horizon Europe about? (2021)
- Germany: EBA Set to Hear Case on the Legality of the EPO’s Video Proceedings, 2021
- Patente treiben Innovation und Fortschritt, 2021
- R 0016/13 – A truly positive decision! (2015)
- In particular with respect to small molecules and biologics attending to and representing crucial patent portfolios and providing freedom-to-operate strategies. Her work includes opposition proceedings, appeal proceedings and petition for review proceedings before the European Patent Office as well as participation in various infringement proceedings and proceedings before the German Constitutional Court, inter alia concerning pain medicaments such as Butrans®/Norspan®.
- German Patent Attorney Association
- AIPPI
- epi
- FICPI
- GRUR
- German
- English
